Medicare’s Cannabis (CBD) Coverage Plan Sparks Federal Controversy
Medicare CBD policy access is a critical issue affecting patient care and clinical practice. Federal controversy surrounds cannabis coverage decisions by CMS. This debate impacts access for millions relying on Medicare.
Scathing Audit for Alabama Medical Marijuana Authority on Eve of Market Launch
The Alabama medical marijuana audit highlights significant regulatory failures affecting patient access and product safety. This audit raises concerns about the oversight of the state's medical cannabis program. Healthcare providers and patients should…
Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics
Hemp-derived extracellular vesicles represent a promising breakthrough in cannabis medicine, offering a natural delivery system for cannabinoids and other compounds. These vesicles provide advantages over mammalian-derived counterparts, including better…
Polycyclic Aromatic Hydrocarbons and Cannabinoids in Secondhand Cannabis Smoke
Secondhand cannabis smoke health risks include exposure to cannabinoids and polycyclic aromatic hydrocarbons (PAHs). This study measures these compounds in real-world environments. Understanding these risks is vital for clinicians and patients.
Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.
This study explores cannabis stigma symptom management among cancer survivors. It assesses patient attitudes and perceptions regarding cannabis use for symptom relief. Findings reveal generally positive views and minimal stigma from healthcare providers.
Cannabigerol Induces ER Stress-Mediated Apoptosis and Ferroptosis in Pancreatic Cancer
Cannabigerol pancreatic cancer cells research reveals dual mechanisms of cell death: apoptosis and ferroptosis. This study highlights the role of endoplasmic reticulum stress via the IRE1α-XBP1 axis. These findings provide promising preclinical insights…
The dual roles of natural cannabidiol in combating oxidative stress and inflammation: A potential intestinal guardian.
CBD antioxidant anti-inflammatory effects play a crucial role in protecting the intestinal tract by reducing oxidative stress and inflammation. This natural compound modulates key pathways to preserve gut barrier integrity. Understanding these effects…
The association between major depressive disorder and cannabis use disorder: A meta-analysis and meta-regression analysis.
This meta-analysis on major depressive disorder cannabis use meta-analysis reveals significant prevalence of co-occurring conditions. It highlights the importance of integrated screening and treatment. Understanding this relationship is crucial for…
Therapeutic Potential of Acidic Cannabinoids: An Update
Acidic cannabinoids therapeutic potential is gaining attention for their unique biological activities. These compounds, including THCA and CBDA, show promise in neuroprotection and anti-inflammatory effects. Current research emphasizes the need for more…
Phase 1 Open-Label Pilot Trial of H4 dTMS for Cannabis Use Disorder
Deep repetitive transcranial magnetic stimulation cannabis use is being studied as a novel intervention for cannabis use disorder. This phase 1 open-label pilot trial evaluates safety and feasibility. The study targets adults with moderate-to-severe…